SELF-TEST FOR SARS-COV-2 ANTIGEN (CORONAVIRUS) - ANVISA Registration 81325990202

Access comprehensive regulatory information for SELF-TEST FOR SARS-COV-2 ANTIGEN (CORONAVIRUS) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 81325990202 and manufactured by manufacturer not specified. The registration is held by QR CONSULTING, IMPORTACAO E DISTRIBUICAO DE PRODUTOS MEDICOS LTDA with validity until Mar 30, 2032.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including GENRUI BIOTECH INC., ASSURE TECH. (HANGZHOU) CO., LTD., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
81325990202
2 Related Devices
Registration Details
ANVISA Registration Number: 81325990202
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Família Teste Rápido do Antígeno SARS-CoV-2 (Nasal) para Autoteste
Risk Class III

Registration Details

81325990202

25351060620202262

19933144000129

Dates and Status

Mar 30, 2022

30/03/2032

09/18/2025 19:00:01

Família Teste Rápido do Antígeno SARS-CoV-2 (Nasal) para Autoteste
Risk Class III

Registration Details

81325990202

25351060620202262

19933144000129

Company Information

China
PT: CHINA, REPÚBLICA POPULAR

Dates and Status

Mar 30, 2022

30/03/2032

09/18/2025 19:00:01